Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Chen, San Marino

Jeffrey M. Chen, San Marino, CA US

Patent application numberDescriptionPublished
20080223864Recognition arrangement for disposable tableware - A recognition arrangement for disposable tableware comprises a tab body having a base portion and a plurality of character portions, and a user reference arrangement, wherein the user reference arrangement has means for selectively removing at least one of the character portions of the tab body that the user can recognize which disposable tableware belonged to him or her. The recognition arrangement can have symbols, numerals or alphabet which helps the user to recognize his or her disposable tableware, helps a user to recognize his or her disposable tableware such that wastage and health risks are reduced. The users can also easily recognize which disposable tableware belong to him or her in a shorter period of time with less effort.09-18-2008
20090266826Recognition arrangement for disposable tableware - A recognition arrangement for disposable tableware includes a container body having a surrounding wall to define a cavity therewithin for containing a predetermined object and a user arrangement which includes a plurality of character portions, wherein the character portions are integrally and spacedly protruding out the surrounding wall of the container body for being selectively to indent each of the character portions, such that the user can recognize which disposable tableware belonged to him or her. The user arrangement can have symbols, numerals or alphabet which helps the user to recognize his or her disposable tableware, helps a user to recognize his or her disposable tableware such that wastage and health risks are reduced. The users can also easily recognize which disposable tableware belongs to him or her in a shorter period of time with less effort.10-29-2009

Patent applications by Jeffrey M. Chen, San Marino, CA US

Kalvin Chen, San Marino, CA US

Patent application numberDescriptionPublished
20090295330DC POWER CONTROL TO MAXIMIZE BATTERY CHARGING TIME - Systems and methods are provided for managing the batteries and the power source as a single combined output to power the load, allowing the system to use power source with reduced maximum power output, reducing system cost and complexity. Furthermore, the switch matrix controller efficiently and dynamically manages the internal power transfer to minimize the charging/discharging cycle of the batteries while ensuring that the power source and the batteries meet changing load power demand. Finally, maximizing charging time and having independent control of each battery increase power efficiency, prolong the operational life of the battery, and increase overall system life.12-03-2009
20110163601POWER CONTROL SYSTEM AND METHOD FOR CHARGING BATTERY USING FLUCTUATING POWER SOURCE - Systems and methods are disclosed for improving power efficiency in battery-charging DC power control systems when a power source input voltage is fluctuating. Power is received from the power sources in the form of AC or DC electrical energy and is controlled and regulated by the DC power control systems into DC voltages for charging batteries and/or for driving output loads. Input voltage from the power sources may fluctuate and may drop below a voltage level required to charge the batteries, resulting in a loss in power conversion efficiency. Embodiments of the present disclosure detect low input voltage, boost the low input voltage to a sufficient voltage level for charging the batteries, and manage the distribution of the battery power and input power to the loads to increase power efficiency while meeting load power demands.07-07-2011

Mike Y. Chen, San Marino, CA US

Patent application numberDescriptionPublished
20100057115SURGICAL METHOD AND CLAMPING APPARATUS FOR REPAIR OF A DEFECT IN A DURAL MEMBRANE OR A VASCULAR WALL, AND ANASTOMIC METHOD AND APPARATUS FOR A BODY - A surgical method and apparatus of repairing a tear, cut or defect in the body tissue, specifically the dura or vascular wall, is disclosed. An inner plate is placed on the tissue's inner surface in a position completely overlapping the tissue defect. An outer plate is placed on the tissue's outer surface in a position completely overlapping the defect and aligned with the inner plate. The inner and outer plates have perimeters larger than the perimeter of the defect and include coiled ribs. The inner plate is coupled to the outer plate such that the peripheral edges of the body tissue defect are securely clamped between the inner and outer plates to provide a watertight repair to the tissue defect.03-04-2010

Raymond H. Chen, San Marino, CA US

Patent application numberDescriptionPublished
20080294106MULTIPLE ROBOTIC INJECTIONS OF ANESTHESIA BASED ON SCANNED IMAGE - A system for relieving pain caused by a tumor within a body may include an injection system having an injector configured to inject an anesthetic within the body to relieve the pain caused by the tumor, and a robotic system configured to position the injector at a plurality of specified, spaced-apart injection locations within the body. A method of relieving pain caused by a tumor within a body may include: generating an image of the tumor within the body; identifying, based on the image, a plurality of locations within the body at which an injection of an anesthetic that relieves the pain caused by the tumor should be made; and making injections of the anesthetic at the locations, under the control of a robotic system that is programmed to make the injections at the identified locations without human intervention between the injections.11-27-2008
20080294107MULTIPLE ROBOTIC INJECTIONS OF PRENATAL MEDICATIONS BASED ON SCANNED IMAGE - A system for delivering a prenatal medication to an unborn fetus within a body may include an injection system having an injector configured to inject the prenatal medication into or in the vicinity of the fetus, and a robotic system configured to position the injector at one or more injection locations within the body. A method of delivering a prenatal medication to an unborn fetus within a body may include generating an image of the fetus within the body; identifying, based on the image, one or more locations within the body at which an injection of the prenatal medication should be made; and making injections into the fetus of the prenatal medication at the locations, under the control of a robotic system that is programmed to make the injections at the identified locations without human intervention between the injections.11-27-2008
20080294115Microscopic Tumor Injection Treatment - A tumor treatment system for treating a tumor within a body may include an injection system having an injector configured to inject an injection within the body that treats the tumor, and a robotic system configured to position the injector at a plurality of specified, spaced-apart treatment locations within the body. A tumor treatment process for treating a tumor within a body may include generating an image of the tumor within the body, identifying a plurality of locations within the body at which an injection that treats the tumor should be made based on the image, and making the injections at the locations under the control of a robotic system that is programmed to make the injections at the identified locations without human intervention.11-27-2008
20080294141MULTIPLE ROBOTIC INJECTIONS OF IMMUNOSUPPRESSIVE DRUGS BASED ON SCANNED IMAGE - A system for delivering an immunosuppressive drug to a transplanted organ within a body may include an injection system having an injector configured to inject an immunosuppressive drug into the transplanted organ, and a robotic system configured to position the injector at one or more injection locations within the body. A method of delivering an immunosuppressive drug to a transplanted organ within a body may include injecting the immunosuppressive drug into one or more locations within the transplanted organ so as to suppress white cell infiltration into the transplanted organ without affecting white cell activity at locations outside of the transplanted organ.11-27-2008
20090253997SKIN BIOPSY WITH AUTOMATED LESION STABILIZATION AND RESECTION - An automated skin biopsy apparatus for taking a biopsy of a lesion on skin. The apparatus may include a lesion stabilizer configure to controllably stabilize the lesion while on the skin, a lesion resector configured to controllably resect the lesion from the skin, a user-operated control, and a controller. The controller may be configured to automatically cause, in response to actuation of the user-operated control by a user, the lesion stabilizer to stabilize the lesion while attached to the skin and the lesion resector to resect the lesion from the skin while the lesion is being stabilized by the lesion stabilizer. Related processes are also disclosed.10-08-2009
20090253998SKIN BIOPSY WITH SUTURING PRIOR TO RESECTION - An automated skin biopsy apparatus for taking a biopsy of a lesion on skin may include a suture applicator configured to controllably suture skin surrounding the lesion before the lesion is resected from the skin, a lesion resector configured to controllably resect the lesion from the skin, a user-operated control, and a controller. The controller may be configured, in response to actuation of the user-operated control by a user, to automatically cause the suture applicator to suture skin surrounding the lesion and the lesion resector to resect the lesion from the skin while the sutures from the suture applicator are in place. Related processes are disclosed.10-08-2009
20100302358AUTOMATED ASSESSMENT OF SKIN LESIONS USING IMAGE LIBRARY - An automated skin lesion assessment system may automatically assess a suspect skin lesion. An electronic image library may contain diagnosed skin lesion image data representative of images of a plurality of diagnosed skin lesions and, for each, a diagnosis of the skin lesion. An image capture system may capture an image of the suspect skin lesion. A computer processing system may compare the image of the suspect skin lesion with the diagnosed skin lesion image data and, based on this comparison, identify one or more diagnosed skin lesions which match the suspect skin lesion. A user interface may report the diagnoses of the diagnosed skin lesions that match the image of the suspect skin lesion.12-02-2010

Patent applications by Raymond H. Chen, San Marino, CA US

Sherwin Chen, San Marino, CA US

Patent application numberDescriptionPublished
20100279353Process of producing fibrinolytic enzyme from mushroom - A fibrinolytic enzyme isolated from a culture broth of a mushroom has a characteristic of degrading a fibrin and a fibrinogen without activating an activity of a plasminogen. The plasminogen is activated to generate a plasmin to degrade the fibrin and/or fibrinogen, so that the fibrinolytic enzyme be used for the thrombosis-related diseases to degrade the fibrin and fibrinogen of blood clots without activate the plasminogen, so as to avoid a hemorrhage due to the over activation the plasminogen to over generate the plasmin.11-04-2010

Shiu Nan Chen, San Marino, CA US

Patent application numberDescriptionPublished
20090098619Method of producing liquid and powered mushroom beta-glucan - A method of producing liquid and powdered mushroom Beta-Glucan provides a uniform culture medium for the mushroom growing well and yielding high beta-glucan production rate. Adapting animal cell culture techniques, the growth of mushroom mycelium is speeded up and the production time is minimized. The use of serum bottles with magnetic stirring units reduces the size of mycelium to promote even distribution in result of better growth. The use of transparent, thermal resistant, and non-toxic polycarbonate (PC) bioreactors with orbital shakers, the fermentation process is better controlled and the production is enhanced while being production cost effective.04-16-2009
20090098620Production method for solid Cultured active mushroom mycelium and fruit-body metabolites (AMFM) products thereof - A production method effectively increases the amount and yield of mushroom beta-glucan, and widely applied in the fields of food, biotechnology, cultivation and medical development. The cultivating medium contains the nutrition of three natural grains, including brown rice, adlay and oat, to provide a complete physiological environment for the mushrooms to grow well. Experimental results strongly suggest that AMFM treated cell activities are significantly enhanced in comparison with those without AMFM treated.04-16-2009
20100279353Process of producing fibrinolytic enzyme from mushroom - A fibrinolytic enzyme isolated from a culture broth of a mushroom has a characteristic of degrading a fibrin and a fibrinogen without activating an activity of a plasminogen. The plasminogen is activated to generate a plasmin to degrade the fibrin and/or fibrinogen, so that the fibrinolytic enzyme be used for the thrombosis-related diseases to degrade the fibrin and fibrinogen of blood clots without activate the plasminogen, so as to avoid a hemorrhage due to the over activation the plasminogen to over generate the plasmin.11-04-2010